Authors
Jon Salmanton-García, Wing-Yan Au, Martin Hoenigl, Louis Yi Ann Chai, Hamid Badali, Ariful Basher, Ronja A Brockhoff, Sharon C-A Chen, Ariya Chindamporn, Anuradha Chowdhary, Christopher H Heath, Kausar Jabeen, Jaehyeon Lee, Madonna Matar, Saad Jaber Taj-Aldeen, Ban Hock Tan, Kenji Uno, Retno Wahyuningsih, Liping Zhu, Arunaloke Chakrabarti, Oliver A Cornely
Publication date
2023/3/1
Journal
International journal of antimicrobial agents
Volume
61
Issue
3
Pages
106718
Publisher
Elsevier
Description
Introduction: Invasive fungal infections (IFIs) in Asia/Pacific are a particular threat to patients with malignancies, uncontrolled diabetes mellitus or undiagnosed/untreated human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS). Adequate and early access to diagnostic tools and antifungals is essential for IFI clinical management and patient survival.
Methods: Details on institution profile, self-perception on IFI, and access to microscopy, culture, serology, antigen detection, molecular testing, and therapeutic drug monitoring for IFI were collected in a survey.
Results: As of June 2022, 235 centres from 40 countries/territories in Asia/Pacific answered the questionnaire. More than half the centres were from six countries: India (25%), China (17%), Thailand (5%), Indonesia, Iran, and Japan (4% each). Candida spp. (93%) and Aspergillus spp. (75%) were considered the most relevant …
Total citations